← Leaderboards
Henrieta Scholtzova
New York University School Of Medicine
$8,346,574
Attributed
$9,356,485
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,356,485 · 6
By mechanism
R01$6,398,651 · 2
R33$1,605,066 · 1
R21$1,352,768 · 3
Top collaborators
- William D Hopkins3 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Shukti Chakravarti$13,351,356
- Yulin Ge$12,393,958
- Agueda Rostagno$1,841,326
- Fernando Goni$2,364,168
- Blas Frangione$6,920,422
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposImpaired CognitionS DiseaseDesignCognitiveElderlyCerebral Amyloid AngiopathyPathologySaimiriPrimatesTau ProteinsAmyloidBiological MarkersTransgenic MiceBrainMagnetic Resonance ImagingNonhuman PrimateFailureBloodImagePathologicAge RelatedBehavioralMonkeys
Grant awards (16)
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA$835,220
R01 · FY2025 · NS · contact PI
A Squirrel Monkey Model of Alzheimerâs Disease: Developing Behavioral, Blood, and CSF Biomarkers$789,521
R33 · FY2025 · AG
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA$821,911
R01 · FY2024 · NS · contact PI
A Squirrel Monkey Model of Alzheimerâs Disease: Developing Behavioral, Blood, and CSF Biomarkers$815,545
R33 · FY2024 · AG
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA$822,959
R01 · FY2023 · NS · contact PI
Characterization of Biomarkers and the Vascular Amyloid Proteome in a Non-human Primate Model of Alzheimerâs Disease$251,916
R21 · FY2023 · NS · contact PI
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA$841,182
R01 · FY2022 · NS · contact PI
Characterization of Biomarkers and the Vascular Amyloid Proteome in a Non-human Primate Model of Alzheimerâs Disease$227,448
R21 · FY2022 · NS · contact PI
Innate Immunity Stimulation via CpG ODN in a Non-Human Primate Model of Sporadic Cerebral Amyloid Angiopathy$538,831
R01 · FY2021 · NS · contact PI
A Squirrel Monkey Model of Alzheimerâs Disease: Developing Behavioral, Blood, and CSF Biomarkers$414,757
R21 · FY2021 · AG
Innate Immunity Stimulation via CpG ODN in a Non-Human Primate Model of Sporadic Cerebral Amyloid Angiopathy$652,338
R01 · FY2020 · NS · contact PI
Innate Immunity Stimulation via CpG ODN in a Non-Human Primate Model of Sporadic Cerebral Amyloid Angiopathy$646,136
R01 · FY2019 · NS · contact PI
Innate Immunity Stimulation via CpG ODN in a Non-Human Primate Model of Sporadic Cerebral Amyloid Angiopathy$560,015
R01 · FY2018 · NS · contact PI
Innate Immunity Stimulation via CpG ODN in a Non-Human Primate Model of Sporadic Cerebral Amyloid Angiopathy$680,059
R01 · FY2017 · NS · contact PI
Testing of Innate Immunity Stimulation via TLR9 on CAA using Non-human Primates.$204,459
R21 · FY2013 · NS · contact PI
Testing of Innate Immunity Stimulation via TLR9 on CAA using Non-human Primates.$254,188
R21 · FY2012 · NS · contact PI